Benjamin Ory

3.6k total citations
60 papers, 2.5k citations indexed

About

Benjamin Ory is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Benjamin Ory has authored 60 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 23 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Benjamin Ory's work include MicroRNA in disease regulation (13 papers), Cancer-related Molecular Pathways (9 papers) and Bone health and treatments (9 papers). Benjamin Ory is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related Molecular Pathways (9 papers) and Bone health and treatments (9 papers). Benjamin Ory collaborates with scholars based in France, United Kingdom and United States. Benjamin Ory's co-authors include Dominique Heymann, Françoise Rédiní, François Lamoureux, Marie‐Françoise Heymann, Leif W. Ellisen, Marc Baud’huin, Marta Tellez Gabriel, Lidia Rodriguez Calleja, Céline Charrier and Frédéric Blanchard and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Benjamin Ory

58 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Ory France	29	1.4k	1.0k	709	611	215	60	2.5k
François Lamoureux France	31	1.6k 1.1×	830 0.8×	567 0.8×	717 1.2×	216 1.0×	73	2.5k
Laura Mercatali Italy	29	1.7k 1.2×	1.8k 1.8×	1.2k 1.7×	768 1.3×	294 1.4×	108	3.7k
Viive M. Howell Australia	26	852 0.6×	672 0.7×	568 0.8×	418 0.7×	152 0.7×	74	2.2k
Takashi Karashima Japan	24	1.1k 0.7×	770 0.7×	547 0.8×	790 1.3×	263 1.2×	119	2.3k
Päivi Auvinen Finland	28	1.6k 1.1×	1.6k 1.5×	901 1.3×	440 0.7×	509 2.4×	75	3.5k
Dmitri Wiederschain United States	28	2.5k 1.7×	1.6k 1.5×	1.2k 1.7×	330 0.5×	321 1.5×	45	3.8k
Nicholas Willumsen Denmark	26	609 0.4×	811 0.8×	455 0.6×	330 0.5×	366 1.7×	82	2.0k
Andrew Sullivan United Kingdom	13	1.2k 0.8×	1.5k 1.5×	717 1.0×	501 0.8×	511 2.4×	23	3.4k
Hetty E. Carraway United States	35	1.7k 1.2×	1.1k 1.0×	399 0.6×	318 0.5×	488 2.3×	212	3.6k
Emiliano Cocco United States	32	1.1k 0.8×	1.6k 1.5×	532 0.8×	833 1.4×	294 1.4×	83	3.2k

Countries citing papers authored by Benjamin Ory

Since Specialization

Citations

This map shows the geographic impact of Benjamin Ory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Ory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Ory more than expected).

Fields of papers citing papers by Benjamin Ory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Ory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Ory. The network helps show where Benjamin Ory may publish in the future.

Co-authorship network of co-authors of Benjamin Ory

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Ory. A scholar is included among the top collaborators of Benjamin Ory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Ory. Benjamin Ory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baze, Audrey, et al.. (2025). Marked differences in thyroxine (T4) metabolism following in vitro exposure of Wistar rat and human hepatocytes to several reference CAR/PXR nuclear receptor activators. Toxicology in Vitro. 104. 106016–106016.

Baud’huin, Marc, et al.. (2024). Abstract 5471: Ribosome heterogeneity and RNA polI inhibition in osteosarcoma heterogeneity. Cancer Research. 84(6_Supplement). 5471–5471.

Charrier, Céline, Bénédicte Brounais-Le Royer, Pierre‐François Cartron, et al.. (2023). Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells. Environmental Health Perspectives. 131(6). 67007–67007. 4 indexed citations

Amiaud, Jérôme, Mélanie Legrand, Régis Brion, et al.. (2021). Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619. Cells. 10(9). 2268–2268. 25 indexed citations

Najm, Aurélie, Benjamin Ory, Thibaut Quillard, et al.. (2020). MicroRNA‐17‐5p Reduces Inflammation and Bone Erosions in Mice With Collagen‐Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast‐like Synoviocytes. Arthritis & Rheumatology. 72(12). 2030–2039. 85 indexed citations

Morice, Sarah, Régis Brion, Bénédicte Brounais-Le Royer, et al.. (2020). The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth. Cancers. 12(12). 3847–3847. 30 indexed citations

Sérandour, Aurélien A., Arulraj Nadaradjane, Dominique Heymann, et al.. (2020). N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool. Molecular Therapy — Nucleic Acids. 22. 72–83. 9 indexed citations

Amiaud, Jérôme, et al.. (2019). Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ Hybridization. Methods in molecular biology. 1914. 169–196. 3 indexed citations

Espitia, Olivier, Mathias Chatelais, Marja Steenman, et al.. (2018). Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification. PLoS ONE. 13(1). e0191976–e0191976. 28 indexed citations

10.

Calleja, Lidia Rodriguez, Camille Jacques, François Lamoureux, et al.. (2016). ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis. Cancer Research. 76(11). 3236–3251. 43 indexed citations

11.

Baud’huin, Marc, François Lamoureux, Camille Jacques, et al.. (2016). Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis. Bone. 94. 10–21. 47 indexed citations

12.

Ory, Benjamin, Marc Baud’huin, Franck Verrecchia, et al.. (2015). Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression. Clinical Cancer Research. 22(10). 2520–2533. 28 indexed citations

13.

Moriceau, Gatien, Benjamin Ory, Céline Charrier, et al.. (2014). Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models. PLoS ONE. 9(3). e90795–e90795. 40 indexed citations

14.

Lamoureux, François, Marc Baud’huin, Lidia Rodriguez Calleja, et al.. (2014). Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle. Nature Communications. 5(1). 3511–3511. 110 indexed citations

15.

Ramsey, Matthew R., Lei He, Nicole Forster, Benjamin Ory, & Leif W. Ellisen. (2011). Physical Association of HDAC1 and HDAC2 with p63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell Carcinoma. Cancer Research. 71(13). 4373–4379. 89 indexed citations

16.

Ory, Benjamin & Leif W. Ellisen. (2011). A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity. Oncotarget. 2(3). 259–264. 45 indexed citations

17.

Vadysirisack, Douangsone D., Franziska Baenke, Benjamin Ory, Kui Lei, & Leif W. Ellisen. (2011). Feedback Control of p53 Translation by REDD1 and mTORC1 Limits the p53-Dependent DNA Damage Response. Molecular and Cellular Biology. 31(21). 4356–4365. 36 indexed citations

18.

Moriceau, Gatien, Benjamin Ory, Laura Mitrofan, et al.. (2010). Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research. 70(24). 10329–10339. 74 indexed citations

19.

Ory, Benjamin, Gatien Moriceau, Valérie Trichet, et al.. (2008). Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells. Journal of Cellular and Molecular Medicine. 12(3). 928–941. 27 indexed citations

20.

Ory, Benjamin, Gatien Moriceau, Françoise Rédiní, & Dominique Heymann. (2007). mTOR Inhibitors (Rapamycin and its Derivatives) and Nitrogen Containing Bisphosphonates: Bi-Functional Compounds for the Treatment of Bone Tumours. Current Medicinal Chemistry. 14(13). 1381–1387. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact